chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt went to Emergency room 2 days after getting the vaccine when pt started having red/raised, pimple-like blisters which became lesions on her face, chest, scalp, thighs, palms of hand, rectum areas. These layers of skin began to fall off. She was then seen by her primary care physician, an allergist and finally by her oncologist who diagnosed her from having adverse reaction to the vaccine. She will be seeing a dermatologist soon. She had no soreness, no swelling, no rashes at site of injection within the first 2 days of the vaccine. She had no soreness, no swelling, no rashes at site of injection within the first 2 days of the vaccine. She has received steroid and EPIPEN injections from various physicians. She is now taking a steroid given to her by her oncologist. She is still sick today 10/3/2010 430pm.
the third dose 2 weeks ago.; the third dose 2 weeks ago.; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 75-years-old male patient received third dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date in 2021 (age at vaccination was unknown) as dose 3 (booster), single for COVID-19 immunization. The patient's medical history included ongoing rheumatoid arthritis. Concomitant medication included methotrexate taken for rheumatoid arthritis. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date in Feb2021 (age at vaccination was unknown) as dose 1, single and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date in Mar2021 (age at vaccination was unknown) as dose 2, single for COVID-19 immunization. The patient stated that he received the first dose of the Pfizer COVID-19 vaccine in Feb2021, the second dose in early Mar2021 and the third dose 2 weeks ago. He took Methotrexate 2 days later for his Rheumatoid Arthritis. He had received 2 doses of Methotrexate since receiving his shot. The patient referenced an article stating that people who take methotrexate may have less effectiveness of the vaccine and that they don't recommend to take methotrexate when anyone take the shot. He was supposed to take another dose of the methotrexate that day. The patient wanted to know how much less effective it was and what could he expect. The case was assessed as non-serious.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Inconsolable high pitched scream along with arching back for hours after vaccination all while refusing to breastfeed. Called doctor they said it was "normal" and to give TYLENOL, we did not give TYLENOL knowing it isn't healthy. Finally passed out do to exhaustion and slept longer than usual.
It was reported that a female patient (2 of 4) was vaccinated with Fluzone SV 2001-2002 vaccine, lot number U0682AA on 10/16/01. Reportedly the patient developed a local reaction of redness and swelling at the injection site. Patient was evaluated by a physician and no therapy was prescribed. This case is linked with reports U200101061, U200101279 and U200101280.
I was having a sore throat and headache for a couple of days, I tested but it was negative. On July 1, 2022 I felt much worse than the days before, this COVID-19 test came back positive. I called my doctor to discuss my symptoms he prescribed PAXLOVID that I started immediately. I feel much better just a bit tired.
swollen, red, painful arm.  low grade fever. same day as vaccine given. Medrol dp prescribed by doctor.
Engerix-B pediatric given to adult.; Engerix-B pediatric given to adult.; This case was reported by a nurse via call center representative and described the occurrence of underdose in a 63-year-old female patient who received HBV (Engerix B pediatric) (batch number 333M4, expiry date 31st July 2024) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 13th September 2022, the patient received Engerix B pediatric and Engerix B Pre-Filled Syringe Device. On 13th September 2022, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 14-Sept-2022 Reporter's comment: The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. Additional supportive information: An adult patient received a pediatric dose of Engerix-B, which led to underdose and adult use of a child product.
48 hours after vaccination, noticed small red spots on and around right axillary. Non-itchy,not raised,not petechiae, not hive like. Some areas are blotchy, and red, as though there are groups of spots. By next morning (10 hours later), the rash had spread from my neck to my groin,including my arms, but not my lower extremities. Group A strep test was negative, to rule out Scarlatina-I do not have a sore throat. Some areas have a slight burning sensation where my clothes may be rubbing.
Information has been received from a doctor of pharmacy concerning a patient who on 21-JUN-2012 was vaccinated with a dose of ZOSTAVAX (Merck) (lot number 669406/1358Z) (dose and route not reported) that was expired. The vaccine expired on 15-JAN-2012. No symptoms were reported. Follow up information has been received from a healthcare professional concerning the patient, an 88 year old male (now 89 years old) who on 21-JUN-2012 (10:25 AM) was vaccinated with a first does of ZOSTAVAX (Merck) (lot number 669406/1358Z) subcutaneously at right arm. The vaccine has expired. Per patient, there were adverse events. Additional information is not expected.
Acute on set of grossly bloody diarrhea. Breast feeding only. No change in infant's or Mom's diet.
This spontaneous report as received from a pharmacist refers to unspecified number of patients of unknown age and gender. On an unknown date, unspecified number of patients may have been vaccinated with VARIVAX (Merck) (strength, dose, route, lot number and expired date unknown) that was stored outside of the original box and exposed to light. No adverse effect was reported. The outcome of administered doses that were outside the original box and exposed to light and no adverse effect was unknown. No further information was provided. This is one of several reports received from same source. Additional information has been requested.
About 24 hours after dose, I started having lower abdominal cramps, then fever, vomiting followed by painful diarrhea for two days. Day 3 vomiting and fever stopped by diarrhea continued. The diarrhea on the 3rd day had blood in it.  From Day 1, severe chills.  Day 4 bleeding stopped, diarrhea slowed enough where I could leave the floor of the bathroom where I was laying and go to bed for periods of time.
I started to have severe ringing in my ears the day after the vaccine. The injection site began to turn red, swollen and hot to the touch. It spread from the injection site to my elbow. It started to go away after 1 week. I went to the Doctor clinic for the ringing in my ears 3 days after the injection. They referred me to a ENT doctor. They performed a hearing test and found moderate hearing loss. I was put on a steroid and that medication did nothing for me. They had me come back 3 months later and it was still not improved. It is still not improved today.
Shortly after receiving injections passed out - no injury - stated lightheaded - hungry. Remained at office 15 -20 minutes. C/O soreness left arm. B/P - good. Syncope with vacs.
Heart Palpitations, increased heart rate greater than 20 bpm of baseline,  chills within 30 minutes post administration. Benadryl taken within 30 minutes of symptom onset.  Weakness and chills 12 hours after administration.  Fever of 100.6 and chills 24-36 hours post administration.
deviated septum; Narrow passageways in her nose/airways were very small; Infected vocal cords; A week later woke up with no voice/Could not talk at all; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received bnt162b2 (COMIRNATY), dose 2 via an unspecified route of administration, administered in right arm on 21Aug2021 around 11:00-12:00 (Lot Number: FC3182) as dose 2, single at the age of 63-year-old for COVID-19 immunization. No medical history. There were no concomitant medications. Historic vaccine was 1st dose of bnt162b2 received on 31Jul2021 (Lot Number: FA7484) as a single dose at the age of 63 years old for COVID-19 immunization. A week later in Aug2021 she woke up with no voice in the morning and couldn't talk at all. A few days later she had barely a whisper. This went on for 2 weeks and she saw an Ear, Nose, and Throat doctor and the doctor recommended the caller report her experience because he hadn't heard of it before. She just had the Covid 19 vaccine and then this happened. The doctor told her that her vocal cords were infected and she has to have surgery. She was prescribed medication because she didn't have her voice back. She took steroids and antibiotics and she finished the medicine and her voice started coming back. The doctor tried to put a camera up her nose and down her throat and the doctor couldn't even get the camera up her nostril. The doctor told her she had narrow passageways in her nose. She was concerned why this happened. She had to get blood work before her surgery. She was having surgery for a deviated septum. She did not know if that was relevant to her losing her voice. The doctor couldn't get the camera in one nostril but the other nostril was fine. Her airways were very small and she wanted to use a CPAP machine but she had to breathe through her nose to use the CPAP. She lost her voice a week after getting the second Covid 19 vaccine and her husband told her she had better go to the Ear, Nose, and Throat doctor. She had never seen the Ear, Nose and Throat doctor before. No additional vaccines administered on same date of the Pfizer suspect. No prior vaccinations within 4 weeks prior to the first administration date of the suspect vaccine. No AE(s) following prior vaccinations. No emergency room visit. Events resulted in physician office visit. Treatment received. The outcome of Infected vocal cords and woke up with no voice/Could not talk at all was recovering. The outcome of other events was unknown.  No follow-up attempts are needed. No further information is expected.
2 minutes following vaccine, pt began experiencing LUE and facial/neck numbness, which has continued for about 1 hour and is improving  slowly. Vaccine given in LUE. Pt denies any respiratory complaints or swelling of neck/mouth.  Neuro exam WNL- sensation to light touch intact to affected areas, cranial nerves WNL, 5/5 strength in all extremities. VSS,  nontoxic. Pt was sent home to continue to monitor symptoms/rest, as they do not appear emergent
SWELLING OF 4-5CM AROUND SITE OF INJECTION WITH REDNESS, SWELLING, HEAT, AND INDURATION.
& ERYTHEMA; SWELLING; INJECTION SITE PAIN ACETAMINOPHEN
Information has been received from a pharmacist concerning an unspecified patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck) (lot #, batch # and route not reported) for prevention of shingles. The pharmacist stated that she heard from an unspecified pharmacist who stated that he heard from another unspecified person that the patient died after receiving ZOSTAVAX (Merck). Attempts are being made to verify the existence of an identifiable patient. No further information is available.
Pain radiating from tips of fingers to neck & shoulders. Numbness & parenthesis to left hand
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 80-year-old female patient who received SHINGRIX (batch number HG4P3, expiry date 13th July 2020). Concomitant products included triamcinolone. On 1st May 2018, the patient received the 1st dose of SHINGRIX. In May 2018, less than a month after receiving SHINGRIX, the patient experienced injection site erythema. The patient was treated with TYLENOL and BENADRYL. On an unknown date, the outcome of the injection site erythema was recovering/resolving. The reporter considered the injection site erythema to be almost certainly related to SHINGRIX. Additional details were reported as follows: The health care professional reported that the patient got dose of SHINGRIX and 8 days later called to report the adverse event. The health care professional advised the patient to take TYLENOL and BENADRYL at the time of her call.
my arms swelled, got very hot; my arms swelled; Rash; This spontaneous report was received from a currently 79-year-old female patient reporting on herself via Pfizer. The patient's allergies included allergy to phenoxyethanol (she got rash). Concurrent conditions, concomitant medications and medical history were not provided.  On an unknown date in 2007, the approximately 65-year-old patient was vaccinated with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) (dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis.  On an unknown date in 2007, she had a reaction to the Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23). The patient experienced rash, her arms swelled and got very hot. The patient was given diphenhydramine hydrochloride (BENADRYL) and she was observed. She did not have any breathing difficulties. The patient knew, that administered vaccine had a preservative (unspecified) in it. The outcome of the events was unknown.  The causal relationship between with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) and the events was reported as related.
Twelve (12) hours post-injection, patient experienced pain at the injection site, low grade fever (98.9), chills, body aches, mild nausea, and mild headache. Symptoms were relieved with Tylenol. On April 22nd (2 days post-injection), patient experienced no side effects during the day.  However, the evening of  April 22nd at 6:30 pm, patient's face felt very hot and then experienced soreness in the sides of the mouth. Patient again had a low-grade fever (98.8) and discovered that painful lesions had suddenly formed in the corner of both sides of the mouth.  At the time this is being reported, patient is still experiencing swollen and painful lesions in the side of the mouth. Patient is disinfecting the wounds with hydrogen peroxide and rubbing  an oral analgesic (Ora gel) on the wounds for pain management.
Patient came into the pharmacy to receive his second dose of the Pfizer Covid-19 vaccine, and he said that he has had persistent dull pain in left arm that he is currently dealing with since his first vaccination. He will seek out a doctor to evaluate his arm.
Confirmed pregnant on November 7th, on December 15th saw doctor for first appt and confirmed pregnancy. On December 31st first ultrasound showed possible conjoined twins. January 6th confirmed with Maternal fetal medicine doctor that I had conjoined twins with anencephaly. Pregnancy had to be terminated on Jan. 7th as I was told the conjoined twins would not make it.
Client noted some mild soreness 11-08-10 evening in area of injection (back of (R) arm). By 8am on 11-09-10 she had an area approx. 3 inches in diameter on back (R) arm that was red, warm, swollen & tender to touch. No soreness or swelling noted in (R) deltoid where Flu vaccine given. Client cannot receive injections in (L) arm. The area increased in size over 11-09-10 and by 11-10-10 arm was (she had husband measure it) 4 inches by 5 inches. Tuesday evening 11-09-10 she did have a temp as high as 101.4 degrees F and did take acetaminophen 3-4 x over next 24 hours to reduce the fever. She also had a headache and ringing in her ears on 11-09-10. On 11-11-10 she felt nauseated but did not vomit and that stopped 11-11-10 evening. She called her MD on 11-10-10, the same morning she called us at the Health Dept. She was not advised to do more than comfort measures (ie ice to area or warm compresses if ice didn't help) or OTC fever reducers. By evening of 11-11-10 reddened, sore, swollen area was decreasing in size. By Sat 11-13-10 the red area was about the size of a quarter but area approx 4 inches or so was still slightly swollen and tender to touch. Did not have fever, nausea, headache or ringing in ears.
Big lump with red mark came up on my left upper arm; A red mark came up on my left upper arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Big lump with red mark came up on my left upper arm) and VACCINATION SITE ERYTHEMA (A red mark came up on my left upper arm) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Asthma. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), CALCIUM and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE MASS (Big lump with red mark came up on my left upper arm) and VACCINATION SITE ERYTHEMA (A red mark came up on my left upper arm). At the time of the report, VACCINATION SITE MASS (Big lump with red mark came up on my left upper arm) and VACCINATION SITE ERYTHEMA (A red mark came up on my left upper arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information does not provided,   This case was linked to MOD-2021-162313 (Patient Link).
Red half way around arm, Swollen half way around arm (looked like a popeye arm), itching. Swelling has went down a little after. This is third day after shot. Had a reaction to first shot also. Not this bad for swelling and no itching. But did sleep the next day all day long. first shot was 2/9/2021.
C.K. received TD vaccine on 06/20/08 and started to experience pain on 06/21/08.  C.K. described his reaction as feeling a significant amount of pain at injection site, as well as swelling at injection site.  Follow up received on 08/15/08: Patient described additional symptoms of redness and erythema at injection site, as well as chills and myalgia.  Patient recovered within days from the onset of the adverse event.
R leg - red, swollen, feeling hot.  Warm wet compress for 15 min four times daily.  LOCOID LIPOCREAM twice daily.
Pain, swelling, redness and warmth to the back of left upper arm that radiates to below elbow.  Patient states it started about 7 hrs after PPV23 injection.
Coughing fit, couldn?t stop for at least 30 mins. Very bad, thought I might need to seek medical attention. Coughed up a bunch of stuff eventually, but cough seemed dry when it was occurring.
Redness, swelling, warm to touch, and mild pain (3/10) at the injection site.
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 12-NOV-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 0.5 mL (Lot # K007822, expiration date 15-AUG-2015) dose, route and anatomical location were not provided. There was no concomitant medication provided. On an unknown date, the PNEUMOVAX had a temperature excursion for 1656 hours, the highest recorded temperature was 59.9 F (15.5 Celsius). The vaccine status was reported as "in excursion", and was storage in a Refrigerator (R). There was no product quality complaint involved and no adverse effects were reported. This is one of several cases received from the same reporter. Additional information has been requested.
Pain in the lower, inner aspect muscle of upper right arm. Radiants to muscle just below the elbow. Both muscles hurt when stretching or picking something, even the TV remote, up; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient (not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number= EJ1686), via an unspecified route of administration at right arm on 19Jan2021 13:45 at single dose for covid-19 immunisation. Medical history included multiple sclerosis, hypertension.  The patient received any other medications within 2 weeks of vaccination as prescribed. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Jan2021, The patient experienced pain in the lower, inner aspect muscle of upper right arm. Radiants to muscle just below the elbow. Both muscles hurt when stretching or picking something, even the TV remote, up. The patient was concerned she may drop something. It started day after having the shot and had been 4 days. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the event was not recovered.
Generalized flare of psoriasis lesions, back, chest, abdomen, buttocks, face and extremities. Went from about 5% to 30%+ of body surface covered by psoriasis lesions.
Tested positive for covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for covid) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced COVID-19 (Tested positive for covid). On 28-Jan-2021, COVID-19 (Tested positive for covid) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment related information has been reported.   This case was linked to MOD-2021-052870 (Patient Link).
Fainted the next morning while making breakfast (after standing for less than 5 minutes). Then spent next 24 hours with intense flu-like symptoms.
Headaches, weakness, sore arm, generalized hives, severe urticaria and fatigue, difficulty swallowing, marked facial edema. 12/17/2008 MR received for ER 10/26/08 and admit 10/27-11/1/2008 with D/C DX: Acute Allergic Reaction with diffuse, severe urticaria and angioedema-felt to be 2' to recent vaccination.  Minimal liver enzyme elevation-felt to be 2' to allergic rxn. Pt initially presented to ER 10/26/08 with urticaria and lip swelling. Tx with steroid and antihistimines with 80% improvement. Returned the next day with worsening urticaria, generalized erythema/rash, and swollen lips, face and eyelids. Readmitted for more IV steroids with 90% improvement.